UQ and CEPI partner with CSL to advance COVID-19 vaccine
A landmark partnership will help to accelerate the future development, manufacture and distribution of a University of Queensland COVID-19 vaccine.
Key points:
- Global biotechnology company CSL will further develop, manufacture and distribute UQ’s COVID-19 vaccine candidate.
- The UQ vaccine is expected to be available in 2021 should clinical trials be successful.